| Combination antiretroviral therapy and the risk of myocardial infarction Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group New England Journal of Medicine 349 (21), 1993-2003, 2003 | 2004 | 2003 |
| HLA-B* 5701 screening for hypersensitivity to abacavir S Mallal, E Phillips, G Carosi, JM Molina, C Workman, J Tomažič, ... New England Journal of Medicine 358 (6), 568-579, 2008 | 1825 | 2008 |
| Association between presence of HLA-B* 5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir S Mallal, D Nolan, C Witt, G Masel, AM Martin, C Moore, D Sayer, ... The Lancet 359 (9308), 727-732, 2002 | 1520 | 2002 |
| A whole-genome association study of major determinants for host control of HIV-1 J Fellay, KV Shianna, D Ge, S Colombo, B Ledergerber, M Weale, ... science 317 (5840), 944-947, 2007 | 1333 | 2007 |
| Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration D: A: D Study Group The Lancet 371 (9622), 1417-1426, 2008 | 1037 | 2008 |
| Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA P Kiepiela, AJ Leslie, I Honeyborne, D Ramduth, C Thobakgale, S Chetty, ... Nature 432 (7018), 769-775, 2004 | 898 | 2004 |
| Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level CB Moore, M John, IR James, FT Christiansen, CS Witt, SA Mallal Science 296 (5572), 1439-1443, 2002 | 884 | 2002 |
| Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection SA Mallal, M John, CB Moore, IR James, EJ McKinnon Aids 14 (10), 1309-1316, 2000 | 597 | 2000 |
| The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases P Price, C Witt, R Allock, D Sayer, M Garlepp, CC Kok, M French, S Mallal, ... Immunological reviews 167 (1), 257-274, 1999 | 572 | 1999 |
| Immune restoration disease after the treatment of immunodeficient HIV‐infected patients with highly active antiretroviral therapy MA French, N Lenzo, M John, SA Mallal, EJ McKinnon, IR James, P Price, ... HIV medicine 1 (2), 107-115, 2000 | 512 | 2000 |
| Adaptation of HIV-1 to human leukocyte antigen class I Y Kawashima, K Pfafferott, J Frater, P Matthews, R Payne, M Addo, ... Nature 458 (7238), 641-645, 2009 | 511 | 2009 |
| Predisposition to abacavir hypersensitivity conferred by HLA-B* 5701 and a haplotypic Hsp70-Hom variant AM Martin, D Nolan, S Gaudieri, CA Almeida, R Nolan, I James, ... Proceedings of the National Academy of Sciences 101 (12), 4180-4185, 2004 | 509 | 2004 |
| Common genetic variation and the control of HIV-1 in humans J Fellay, D Ge, KV Shianna, S Colombo, B Ledergerber, ET Cirulli, ... PLoS Genet 5 (12), e1000791, 2009 | 403 | 2009 |
| Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes B Ledergerber, PLATO collaboration The Lancet 364 (9428), 51-62, 2004 | 376 | 2004 |
| Effects of CCR5-32, CCR2-64I, and SDF-1 3 A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data IP Data Ann Intern Med 135, 782-795, 2001 | 363* | 2001 |
| Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 … TM Allen, M Altfeld, SC Geer, ET Kalife, C Moore, KM O'sullivan, ... Journal of virology 79 (21), 13239-13249, 2005 | 357 | 2005 |
| High sensitivity of human leukocyte antigen-b* 5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients M Saag, R Balu, E Phillips, P Brachman, C Martorell, W Burman, B Stancil, ... Clinical infectious diseases 46 (7), 1111-1118, 2008 | 352 | 2008 |
| Predisposition to nevirapine hypersensitivity associated with HLA-DRB1* 0101 and abrogated by low CD4 T-cell counts AM Martin, D Nolan, I James, P Cameron, J Keller, C Moore, E Phillips, ... Aids 19 (1), 97-99, 2005 | 349 | 2005 |
| T cells from patients with Parkinson’s disease recognize α-synuclein peptides D Sulzer, RN Alcalay, F Garretti, L Cote, E Kanter, J Agin-Liebes, C Liong, ... Nature 546 (7660), 656-661, 2017 | 344 | 2017 |
| Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire DA Ostrov, BJ Grant, YA Pompeu, J Sidney, M Harndahl, S Southwood, ... Proceedings of the National Academy of Sciences 109 (25), 9959-9964, 2012 | 342 | 2012 |
